The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of an individualized starting-dose of niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics; SeraCare
Stock and Other Ownership Interests - Karyopharm Therapeutics; SeraCare
Honoraria - Advaxis; AstraZeneca; Cerulean Pharma; Clovis Oncology; Novocure; Pfizer; Roche; tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Cerulean Pharma; Clovis Oncology; Genmab; Karyopharm Therapeutics; Novocure; Pfizer; Sotio; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Karyopharm Therapeutics; Pfizer; Roche; SeraCare; Tesaro
 
Antonio Gonzalez Martin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; ImmunoGen; Merck/Pfizer; MSD; Oncoinvent; PharmaMar; Roche; Tesaro
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro
Research Funding - Roche; Tesaro
Expert Testimony - AstraZeneca; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
 
Whitney Graybill
Consulting or Advisory Role - Tesaro
Speakers' Bureau - Tesaro
 
David M. O'Malley
No Relationships to Disclose
 
Lydia Gaba
No Relationships to Disclose
 
Oi Wah S. Yap
No Relationships to Disclose
 
Eva M. Guerra
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck Sharp & Dohme; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Baxter; GlaxoSmithKline/Tesaro; Roche
 
Peter Graham Rose
No Relationships to Disclose
 
Jean-Francois Baurain
No Relationships to Disclose
 
Sharad A. Ghamande
Consulting or Advisory Role - Seagen
Speakers' Bureau - Tesaro/GSK
Research Funding - Site PI, GSK/Merck/Roche/Genetech/Takeda/Seattle genetics/Advaxis/BMS/Clovis/Abbvie/Tesaro
 
Hannelore denys
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst)
 
Emily Prendergast
Consulting or Advisory Role - AstraZeneca/Merck
 
Carmela Pisano
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Tesaro
 
Philippe Follana
Expert Testimony - AstraZeneca; Ipsen; Novartis; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; tesaro
 
Klaus Baumann
No Relationships to Disclose
 
Paula Calvert
No Relationships to Disclose
 
Jacob Korach
Consulting or Advisory Role - AstraZeneca; MSD Oncology
 
Yong Li
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Divya Gupta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Agenus; Amgen; AstraZeneca; ChemoCare; ChemoID; Clovis Oncology; Conjupro Biotherapeutics; Eisai; Geistlich Pharma; Genmab; Immunogen; Immunomedics; Incyte; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; OncoQuest; Perthera; Pfizer; Precision Oncology; Puma Biotechnology; Roche/Genentech; Samumed; Takeda; Tesaro; VBL Therapeutics
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Cerulean Pharma; ChemoCare; ChemoID; Clovis Oncology; Eisai; Geistlich Pharma; Immunogen; Incyte; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; OncoMed; OncoSec; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Samumed; Takeda; Tesaro; VBL Therapeutics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)